They observed that FTO inhibition induced by small-molecule compounds, downregulated the immune checkpoint gene leukocyte immunoglobulin-like receptor subfamily B4 (LILRB4), with a greater tendency than PD-L1/2, further sensitized leukemia cells to T cell cytotoxicity and overcame HMA-induced immune evasion [150]. This evidence concerns the gene FTO and leukemia.